KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Teladoc Health (TDOC) over the last 12 years, with Q3 2025 value amounting to $2.6 million.

  • Teladoc Health's Deferred Taxes rose 44649.93% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$33.2 million, marking a year-over-year decrease of 71880.36%. This contributed to the annual value of -$1.1 million for FY2024, which is 3983.18% up from last year.
  • Latest data reveals that Teladoc Health reported Deferred Taxes of $2.6 million as of Q3 2025, which was up 44649.93% from -$7.2 million recorded in Q2 2025.
  • Teladoc Health's 5-year Deferred Taxes high stood at $87.0 million for Q1 2021, and its period low was -$49.6 million during Q4 2021.
  • Moreover, its 5-year median value for Deferred Taxes was -$1.8 million (2024), whereas its average is -$28263.2.
  • Its Deferred Taxes has fluctuated over the past 5 years, first soared by 318524.82% in 2021, then crashed by 157906.25% in 2025.
  • Quarter analysis of 5 years shows Teladoc Health's Deferred Taxes stood at -$49.6 million in 2021, then soared by 96.17% to -$1.9 million in 2022, then soared by 350.53% to $4.8 million in 2023, then crashed by 136.93% to -$1.8 million in 2024, then skyrocketed by 249.37% to $2.6 million in 2025.
  • Its Deferred Taxes stands at $2.6 million for Q3 2025, versus -$7.2 million for Q2 2025 and -$26.9 million for Q1 2025.